White Paper

Patient-Centricity By Design

Source: IQVIA Research & Development Solutions

By Katie Shaw, Senior Director, Patient Recruitment & Enablement, IQVIA Kelly Sanford, Global Head of Site Operations, IQVIA Decentralized Trials, and Mark Mentzer, Director, IQVIA Connected Devices

patient recruitment iStock-1299220556

The COVID-19 pandemic has redefined the relationship between patients, technology and clinical research. When healthcare centers shut down, sponsors relied on decentralized clinical trial (DCT) models to keep patients and staff safe, while continuing to move research forward. In making this transition they discovered additional benefits of DCTs that take patient preferences and needs into consideration and include connected devices to drive greater efficiency and engagement.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader